CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Shares withheld for taxes Chief Scientific Officer gave up 41,187 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 24,552 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 14,426 shares at $1.09 ($15,724)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 28,270 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 28,325 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, President US gave up 28,214 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 7,730 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, President US gave up 15,460 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 23,525 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, President US gave up 23,525 shares (to pay taxes)
- 4 Planned sale Chief Scientific Officer sold 34,131 shares at $0.79 ($26,963)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 300,000 shares at an average $1.04 ($312,315)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, President US gave up 11,763 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 11,763 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 31 · 620 filings